<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39340461</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2385-2011</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences</Title><ISOAbbreviation>Interv Neuroradiol</ISOAbbreviation></Journal><ArticleTitle>Characteristics of middle cerebral artery aneurysms treated endovascularly in a clip-favored institution.</ArticleTitle><Pagination><StartPage>15910199241286242</StartPage><MedlinePgn>15910199241286242</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/15910199241286242</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The emergence of flow disruptors has brought a dynamic transition in the selection of treatment for middle cerebral artery (MCA) aneurysms, and the number of MCA aneurysms clipped is acceleratingly decreasing. Still, retreatment after endovascular treatment is still a dilemma, which may necessitate surgical clipping. It is all the more important to elucidate characteristics of MCA aneurysms that make clipping unfavorable. Thus, the practical characteristics of MCA aneurysms treated endovascularly in a clip-favored institution before the usage of flow disruption devices were investigated.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a retrospective, single-center observational study. The clinical and imaging characteristics of treated MCA aneurysms from January 2012 to May 2022 were analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 83 aneurysms were included; 70 aneurysms (84%) were clipped, and 13 (16%) were treated endovascularly. Eighteen aneurysms (22%) were ruptured (clipping, 12; endovascular, 6). The reasons for an endovascular treatment were as follows: distal (3); subacutely ruptured with burdens of spasm (2); multiple aneurysms (6: another clipped in 3, coiled in 1, and conservatively managed in 2); no access to the operating room due to COVID-19 (1); and retreatment after coiling (1). Endovascular group aneurysms were smaller (maximum diameter 5.2 vs 7.3 mm, <i>p</i> &lt; 0.01, as well as dome, neck, and height) without differences in the dome/neck and aspect (height/neck) ratios. In a subgroup analysis of 78 MCA bifurcation aneurysms, the endovascular group was still smaller (dome 4.4 vs 5.8 mm, <i>p</i> = 0.025; neck 2.8 vs 3.9, <i>p</i> = 0.03).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In a limited series from a clip-favored institution before the flow disruption era, factors guided to endovascular treatments on MCA aneurysms were rather anatomical and clinical factors such as distal location, subacutely ruptured, multiple, or retreatment after coiling, than morphological factors such as dome/neck and aspect ratios albeit smaller size.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kiyofuji</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8780-5773</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation><Identifier Source="RINGGOLD">13143</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koizumi</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation><Identifier Source="RINGGOLD">13143</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kin</LastName><ForeName>Taichi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation><Identifier Source="RINGGOLD">13143</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyawaki</LastName><ForeName>Satoru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation><Identifier Source="RINGGOLD">13143</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hongo</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation><Identifier Source="RINGGOLD">13143</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umekawa</LastName><ForeName>Motoyuki</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7722-9861</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation><Identifier Source="RINGGOLD">13143</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Nobuhito</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.</Affiliation><Identifier Source="RINGGOLD">13143</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Interv Neuroradiol</MedlineTA><NlmUniqueID>9602695</NlmUniqueID><ISSNLinking>1591-0199</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clipping</Keyword><Keyword MajorTopicYN="N">coil</Keyword><Keyword MajorTopicYN="N">endovascular treatment</Keyword><Keyword MajorTopicYN="N">intracranial aneurysm</Keyword><Keyword MajorTopicYN="N">middle cerebral artery aneurysm</Keyword></KeywordList><CoiStatement>Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39340461</ArticleId><ArticleId IdType="doi">10.1177/15910199241286242</ArticleId></ArticleIdList></PubmedData></PubmedArticle>